Sarepta Therapeutics, Inc. (SRPT)
17.10
-0.69
(-3.88%)
USD |
NASDAQ |
Oct 16, 16:00
17.10
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Net Income (TTM) : -266.10M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -266.10M |
| March 31, 2026 | -64.32M |
| December 31, 2025 | -842.79M |
| September 30, 2025 | -271.51M |
| June 30, 2025 | -57.96M |
| March 31, 2025 | -248.39M |
| December 31, 2024 | 235.24M |
| September 30, 2024 | 121.84M |
| June 30, 2024 | 47.30M |
| March 31, 2024 | 16.90M |
| December 31, 2023 | -535.98M |
| September 30, 2023 | -690.88M |
| June 30, 2023 | -907.68M |
| March 31, 2023 | -1.115B |
| December 31, 2022 | -703.49M |
| September 30, 2022 | -716.22M |
| June 30, 2022 | -506.63M |
| March 31, 2022 | -356.56M |
| December 31, 2021 | -418.78M |
| September 30, 2021 | -486.12M |
| June 30, 2021 | -634.47M |
| March 31, 2021 | -703.89M |
| December 31, 2020 | -554.13M |
| September 30, 2020 | -600.51M |
| June 30, 2020 | -530.34M |
| Date | Value |
|---|---|
| March 31, 2020 | -655.92M |
| December 31, 2019 | -715.08M |
| September 30, 2019 | -620.27M |
| June 30, 2019 | -570.33M |
| March 31, 2019 | -403.20M |
| December 31, 2018 | -361.92M |
| September 30, 2018 | -245.02M |
| June 30, 2018 | -216.36M |
| March 31, 2018 | -170.14M |
| December 31, 2017 | -50.69M |
| September 30, 2017 | -115.14M |
| June 30, 2017 | -124.15M |
| March 31, 2017 | -123.40M |
| December 31, 2016 | -267.26M |
| September 30, 2016 | -243.49M |
| June 30, 2016 | -238.69M |
| March 31, 2016 | -218.24M |
| December 31, 2015 | -220.03M |
| September 30, 2015 | -199.76M |
| June 30, 2015 | -177.05M |
| March 31, 2015 | -169.08M |
| December 31, 2014 | -135.79M |
| September 30, 2014 | -100.19M |
| June 30, 2014 | -113.00M |
| March 31, 2014 | -98.17M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Moderna, Inc. | -3.151B |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Beam Therapeutics, Inc. | -85.43M |
| Rocket Pharmaceuticals, Inc. | -17.25M |
| Intellia Therapeutics, Inc. | -399.98M |